3/12
12:08 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
3/12
12:08 pm
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $51.00 price target on the stock.
3/12
08:05 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock, down previously from $75.00.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $50.00 price target on the stock, down previously from $75.00.
3/11
03:11 pm
crbp
Rating for CRBP
Low
Report
Rating for CRBP
3/11
03:11 pm
crbp
Rating for CRBP
Low
Report
Rating for CRBP
2/28
07:22 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/28
07:22 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/28
07:21 am
crbp
Rating for CRBP
Low
Report
Rating for CRBP
2/28
07:21 am
crbp
Rating for CRBP
Low
Report
Rating for CRBP
2/28
05:25 am
crbp
Corbus Pharmaceuticals initiated with an Outperform at William Blair
Low
Report
Corbus Pharmaceuticals initiated with an Outperform at William Blair
2/28
05:25 am
crbp
Corbus Pharmaceuticals initiated with an Outperform at William Blair
Low
Report
Corbus Pharmaceuticals initiated with an Outperform at William Blair
2/18
08:00 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
Medium
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock.
2/10
08:00 am
crbp
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock, down previously from $80.00.
High
Report
Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $75.00 price target on the stock, down previously from $80.00.